CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hunan Nucien Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hunan Nucien Pharmaceutical Co Ltd
Building 1-2
No.196 Kaiyuan Avenue, Luogang District
Phone: +86 2038952013p:+86 2038952013 GUANGZHOU, GNG  510100  China Ticker: 688189688189
Business Summary
Hunan Nucien Pharmaceutical Co Ltd is a China-based company mainly engaged in chemical drugs business. The Company focuses on the research and development, production and marketing of chemical drugs, and is committed to the research, development and industrialization of new drugs and special effects drugs for major diseases and sudden diseases to meet the needs of clinical drugs. The indications of the Company's products include anti-virus, cardio-cerebral-vascular, antibiotics and other medical fields. The Company mainly operates its business in the domestic market.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board WenxunYang 60 12/1/2009 12/1/2009
Vice Chairman of the Board, General Manager ShixiZhang 49 12/20/2023 12/1/2016
Chief Financial Officer, Deputy General Manager LiangLi 47 11/5/2023 2/1/2019
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 360 (As of 12/31/2023)
Outstanding Shares: 274,400,000 (As of 9/30/2024)
Shareholders: 10,722
Stock Exchange: SHA
Fax Number: +86 2080672369


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024